Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

4.320 +0.080 (+1.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
GoodRx Offers Free Telehealth Appointments to Kentucky Residents Affected by Flooding
From GoodRx
Via Business Wire
GoodRx to Present Virtually at the Bank of America SMID Cap Ideas Conference
From GoodRx Holdings, Inc.
Via Business Wire
These Were The Five Best And Worst Performing Mid-Cap Stocks In H1 2022
Investors who want to make quick returns while having some stability amid the current volatile market environment can go for mid-cap stocks. Let’s take a look at the five best and worst performing... 
Via Talk Markets
Expert Ratings for GoodRx Holdings
Analysts have provided the following ratings for GoodRx Holdings (NASDAQ:GDRX) within the last quarter: 
Via Benzinga
Expert Ratings for GoodRx Holdings
Within the last quarter, GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings: 
Via Benzinga
16 Analysts Have This to Say About GoodRx Holdings
Over the past 3 months, 16 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Is Cloud DX Poised To Innovate Its Way Into The $250 Billion Telehealth Opportunity?
With the outbreak of the COVID-19 pandemic in 2020, telehealth usage reportedly soared to unprecedented levels, as both consumers and health care providers sought ways to safely access and deliver... 
Via Benzinga
GoodRx Announces Date for Second Quarter 2022 Earnings Release and Conference Call
From GoodRx Holdings Inc.
Via Business Wire
Baird Maintains Neutral Rating for GoodRx Holdings: Here's What You Need To Know
Baird has decided to maintain its Neutral rating of GoodRx Holdings (NASDAQ:GDRX) and lower its price target from $7.00 to $6.00. Shares of GoodRx Holdings are trading up 6.94% over the last 24 hours,... 
Via Benzinga
91 Biggest Movers From Friday
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto. 
Via Benzinga
44 Stocks Moving In Friday's Mid-Day Session
Gainers Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 10, 2022
Via Benzinga
25 Stocks Moving in Friday's Pre-Market Session
Gainers Regis Corporation (NYSE: RGS) rose 74.4% to $0.9753 in pre-market trading. Regis partnered with salon technology provider Zenoti to support its 5,000+ locations. 
Via Benzinga
Medical Metaverse — Is This Company At The Forefront Of Digital-Medical Technological Advancement?
Photo by julien Tromeur on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022
Upgrades 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 73 stocks hit new 52-week lows. 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Keybanc cut Ambarella, Inc. (NASDAQ: AMBA) price target from $160 to $120. Ambarella shares fell 5% to $81.00 in pre-market trading. 
Via Benzinga
NASDAQ:GDRX Shareholder Notice: Update Announced in Lawsuit Against GoodRx Holdings, Inc.
San Diego, CA -- (SBWIRE) -- 05/31/2022 -- An update was announced in the lawsuit that is pending for certain investors in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX). 
Via SBWire
Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of GoodRx Holdings, Inc. (GDRX) Investors
From Kirby McInerney LLP
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Continues Its Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
GoodRx and RxVantage Announce Strategic Relationship to Streamline Communications Between Providers and Manufacturers
From GoodRx
Via Business Wire
GOODRX ALERT: Bragar Eagel & Squire, P.C. Is Investigating GoodRx, Inc. on Behalf of GoodRx Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of GoodRx Holdings, Inc. (GDRX) Investors
From Kirby McInerney LLP
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
From Smith Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Peak Or Persist? Investors Parse April's Hotter-than-Expected 8.3% Inflation Jump
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Goldman Sachs Maintains Buy Rating for GoodRx Holdings: Here's What You Need To Know
Goldman Sachs has decided to maintain its Buy rating of GoodRx Holdings (NASDAQ:GDRX) and lower its price target from $30.00 to $12.00. Shares of GoodRx Holdings are trading up 1.32% over the last 24... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.